Breast cancer-specific survival (BCSS) in patients (pts) with nodenegative (N0) and node-positive (N+) breast cancer (BC) guided by the 21-gene assay: a SEER-genomic real-world evidence study. (March 2019) - Winer, E.P.; Shak, S.; Sledge, G.W.; Albain, K.S.; Mamounas, E.P.; Jakubowski, D.M.; Petkov, V.I.; Wolmark, N.; Hortobagyi, G.N.